Sanofi India · NSE: SANOFI · BSE: 500674
Q3 FY26 results · Oct–Dec 2025
Sanofi India reported revenue from operations of ₹419.80 crore (down 18.5% from Q3 FY25) and net profit of ₹61.70 crore (down 32.4% from Q3 FY25) for Q3 FY26 (Oct–Dec 2025), on a standalone basis.
| Item | Q3 FY26 | Q3 FY25 | YoY | Q2 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 419.80 | 514.90 | −18.5% | 475.40 | −11.7% |
| Other income | 2.80 | 5.90 | −52.5% | 4.90 | −42.9% |
| Total income | 422.60 | 520.80 | −18.9% | 480.30 | −12.0% |
| Profit before tax | 83.00 | 122.20 | −32.1% | 102.30 | −18.9% |
| Net profit for the period | 61.70 | 91.30 | −32.4% | 76.00 | −18.8% |
| EPS, basic (₹) | 26.79 | 39.64 | −32.4% | 32.99 | −18.8% |
| Net margin (%) | 14.7 | 17.7 | 16.0 |
Standalone
- Filed with BSE
- 25 Feb 2026, 19:30 IST
- Board meeting
- 25 Feb 2026
- Period
- 01 Oct 2025 to 31 Dec 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE